Three’s A Crowd: Celltrion Picks Up Latest US Tocilizumab Nod

Avtozma Biosimilar To Actemra Is Third To Be Approved By US FDA

 
• By Dave Wallace
  
A third tocilizumab biosimilar has been approved in the US (Shutterstock)

More from Biosimilars

More from Generics Bulletin